{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:44:00Z","timestamp":1762821840142,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"am","delay-in-days":423,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.retram.2023.103426","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T20:54:12Z","timestamp":1698353652000},"page":"103426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytogenetics in the management of clonal chromosomal abnormalities of undetermined significance and persistent polyclonal B-cell lymphocytosis: Guidelines from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8424-5141","authenticated-orcid":false,"given":"N.","family":"Nadal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9744-4470","authenticated-orcid":false,"given":"N.","family":"Auger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0992-8377","authenticated-orcid":false,"given":"A.","family":"Bidet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3107-6668","authenticated-orcid":false,"given":"F.","family":"Nguyen-Khac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"An international system for human cytogenomic nomenclature","author":"McGowan-Jordan","key":"10.1016\/j.retram.2023.103426_bib0001"},{"key":"10.1016\/j.retram.2023.103426_bib0002","first-page":"1101","article-title":"The frequency of aneuploidy in cultured lymphocytes is correlated with age and gender but not with reproductive history","volume":"46","author":"Nowinski","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.retram.2023.103426_bib0003","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0165-4608(98)00003-X","article-title":"Trisomy 15 associated with loss of the Y chromosome in bone marrow: a possible new aging effect","volume":"105","author":"Sinclair","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.retram.2023.103426_bib0004","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0165-4608(00)00253-3","article-title":"Trisomy 15 is frequently observed as a minor clone in patients with Anemia\/MDS\/NHL and as a major clone in patients with AML","volume":"121","author":"Batanian","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.retram.2023.103426_bib0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000133945","article-title":"Trisomy 7 in nonneoplastic epithelial kidney cells","volume":"69","author":"Elfving","year":"1995","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.retram.2023.103426_bib0006","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00439-020-02114-w","article-title":"Mosaic loss of human Y chromosome: what, how and why","volume":"139","author":"Guo","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.retram.2023.103426_bib0007","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/bjh.13251","article-title":"Sex chromosome loss in adults with haematological neoplasms","volume":"169","author":"Cant\u00fa","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2023.103426_bib0008","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0165-4608(99)00042-4","article-title":"Frequency of trisomy 15 and loss of the Y chromosome in adult leukemia","volume":"114","author":"Smith","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.retram.2023.103426_bib0009","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/gcc.2870050112","article-title":"Loss of the Y chromosome from normal and neoplastic bone marrows","volume":"5","year":"1992","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.retram.2023.103426_bib0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41431-019-0533-z","article-title":"Longitudinal changes in the frequency of mosaic chromosome Y loss in peripheral blood cells of aging men varies profoundly between individuals","volume":"28","author":"Danielsson","year":"2020","journal-title":"Eur J Hum Genet EJHG"},{"key":"10.1016\/j.retram.2023.103426_bib0011","doi-asserted-by":"crossref","first-page":"72356","DOI":"10.18632\/oncotarget.12050","article-title":"Sex chromosome loss and the pseudoautosomal region genes in hematological malignancies","volume":"7","author":"Weng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.retram.2023.103426_bib0012","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1126\/science.abn3100","article-title":"Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality","volume":"377","author":"Sano","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.retram.2023.103426_bib0013","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.5858\/2008-132-1329-LOTYCA","article-title":"Loss of the Y chromosome: an age-related or clonal phenomenon in acute myelogenous leukemia\/myelodysplastic syndrome?","volume":"132","author":"Wong","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.retram.2023.103426_bib0014","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1098-2264(200001)27:1<11::AID-GCC2>3.0.CO;2-I","article-title":"Clinical significance of Y chromosome loss in hematologic disease","volume":"27","author":"Wiktor","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.retram.2023.103426_bib0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3324\/haematol.2019.240689","article-title":"Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells","volume":"106","author":"Ouseph","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2023.103426_bib0016","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.leukres.2016.05.023","article-title":"Clinical significance of acquired loss of the X chromosome in bone marrow","volume":"47","author":"Tang","year":"2016","journal-title":"Leuk Res"},{"key":"10.1016\/j.retram.2023.103426_bib0017","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-4608(96)00020-9","article-title":"Trisomy 15 in hematological malignancies: six cases and review of the literature","volume":"89","author":"Smith","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.retram.2023.103426_bib0018","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1309\/2VQLDHVJB9YW83KB","article-title":"Isolated trisomy 15: a clonal chromosome abnormality in bone marrow with doubtful hematologic significance","volume":"129","author":"Hanson","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.retram.2023.103426_bib0019","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.leukres.2014.11.005","article-title":"Isolated +15 in bone marrow: disease-associated or a benign finding?","volume":"39","author":"Goswami","year":"2015","journal-title":"Leuk Res"},{"key":"10.1016\/j.retram.2023.103426_bib0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0165-4608(94)00099-W","article-title":"Myelodysplastic syndrome in a child with constitutional trisomy 8 mosaicism and normal phenotype","volume":"79","author":"Hasle","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.retram.2023.103426_bib0021","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF01213097","article-title":"Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark","volume":"87","author":"Nielsen","year":"1991","journal-title":"Hum Genet"},{"key":"10.1016\/j.retram.2023.103426_bib0022","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/(SICI)1098-2264(199610)17:2<94::AID-GCC4>3.0.CO;2-W","article-title":"Constitutional trisomy 8 as first mutation in multistep carcinogenesis: clinical, cytogenetic, and molecular data on three cases","volume":"17","author":"Seghezzi","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.retram.2023.103426_bib0023","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2141.2011.08817.x","article-title":"Constitutional trisomy 8p11.21-q11.21 mosaicism: a germline alteration predisposing to myeloid leukaemia","volume":"155","author":"Ripperger","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2023.103426_bib0024","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ajmg.a.20390","article-title":"Constitutional trisomy 8 mosaicism due to meiosis II non-disjunction in a phenotypically normal woman with hematologic abnormalities","author":"Baidas","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.retram.2023.103426_bib0025","unstructured":"Atlas of Genetics and Cytogenetics in Oncology and Haematology [Internet]. [cited 2023 Mar 14]. Available from: https:\/\/www.atlasgeneticsoncology.org\/."},{"key":"10.1016\/j.retram.2023.103426_bib0026","first-page":"S145","article-title":"A reappraisal of the association between Beh\u00e7et's disease, myelodysplastic syndrome and the presence of trisomy 8: a systematic literature review","volume":"33","author":"Esatoglu","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.retram.2023.103426_bib0027","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/bjh.15490","article-title":"Myelodysplastic syndrome (MDS) with isolated trisomy 8: a type of MDS frequently associated with myeloproliferative features? A report by the Groupe Francophone des My\u00e9lodysplasies","volume":"182","author":"Drevon","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2023.103426_bib0028","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103426_bib0029","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2023.103426_bib0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/10428194.2016.1203432","article-title":"Clinicopathologic evaluation of cytopenic patients with isolated trisomy 8: a detailed comparison between idiopathic cytopenia of unknown significance and low-grade myelodysplastic syndrome","volume":"58","author":"Petrova-Drus","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.retram.2023.103426_bib0031","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ajh.24347","article-title":"Clinical course of patients with incidental finding of 20q- in the bone marrow without a morphologic evidence of myeloid neoplasm","volume":"91","author":"Jawad","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.retram.2023.103426_bib0032","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103426_bib0033","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41408-020-0275-8","article-title":"The significance of genetic mutations and their prognostic impact on patients with incidental finding of isolated del(20q) in bone marrow without morphologic evidence of a myeloid neoplasm","volume":"10","author":"Ravindran","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.retram.2023.103426_bib0034","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103426_bib0035","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103426_bib0036","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1182\/blood.V83.4.931.931","article-title":"Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe","volume":"83","author":"Fey","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103426_bib0037","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1182\/blood-2017-01-763425","article-title":"Clinical significance of somatic mutation in unexplained blood cytopenia","volume":"129","author":"Malcovati","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103426_bib0038","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/EDBK_239083","article-title":"Definition, Implications, and Impact on Practice","volume":"39","author":"DeZern","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet"},{"key":"10.1016\/j.retram.2023.103426_bib0039","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200310","article-title":"Prediction of risk for myeloid malignancy in clonal hematopoiesis","volume":"2","author":"Weeks","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.retram.2023.103426_bib0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41586-018-0497-0","article-title":"Population dynamics of normal human blood inferred from somatic mutations","volume":"561","author":"Lee-Six","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.retram.2023.103426_bib0041","unstructured":"WHO Classification of Tumours Online [Internet]. [cited 2023 Apr 6]. Available from:https:\/\/tumourclassification.iarc.who.int\/welcome\/."},{"key":"10.1016\/j.retram.2023.103426_bib0042","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/gcc.23107","article-title":"The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high-risk clonal cytopenia of unknown significance","volume":"62","author":"Brett","year":"2023","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.retram.2023.103426_bib0043","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.1994.tb05018.x","article-title":"Persistent polyclonal lymphocytosis with binucleated B lymphocytes: a genetic predisposition","volume":"88","author":"Troussard","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2023.103426_bib0044","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1746-1596-7-107","article-title":"Histological and immunohistochemical features of the spleen in persistent polyclonal B-cell lymphocytosis closely mimic splenic B-cell lymphoma","volume":"7","author":"Sun","year":"2012","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.retram.2023.103426_bib0045","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3390\/jcm10153374","article-title":"Patients with persistent polyclonal B-cell lymphocytosis share the symptomatic criteria of systemic exertion intolerance disease","volume":"10","author":"Morizot","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.retram.2023.103426_bib0046","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/OTT.S4182","article-title":"Polyclonal B-cell lymphocytosis with binucleated lymphocytes (PPBL)","volume":"1","author":"Troussard","year":"2008","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.retram.2023.103426_bib0047","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3109\/10428194.2013.843680","article-title":"Morphologic features of binucleated lymphocytes to assess the diagnosis of persistent B-cell polyclonal lymphocytosis or other mature B-cell neoplasms","volume":"55","author":"Lesesve","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.retram.2023.103426_bib0048","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1365-2141.1999.01200.x","article-title":"Persistent polyclonal B lymphocytosis with binucleated lymphocytes: a study of 25 cases. Groupe Fran\u00e7ais d'H\u00e9matologie Cellulaire","volume":"104","author":"Mossafa","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2023.103426_bib0049","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2141.1997.4233234.x","article-title":"Distribution of the cytogenetic abnormality +i(3)(q10) in persistent polyclonal B-cell lymphocytosis: a FICTION study in three cases","volume":"99","author":"Callet-Bauchu","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2023.103426_bib0050","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1080\/10428194042000191738","article-title":"Chromosomal instability and ATR amplification gene in patients with persistent and polyclonal B-cell lymphocytosis (PPBL)","volume":"45","author":"Mossafa","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.retram.2023.103426_bib0051","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13104-015-1742-3","article-title":"Persistent polyclonal binucleated B-cell lymphocytosis and MECOM gene amplification","volume":"9","author":"Cornet","year":"2016","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.retram.2023.103426_bib0052","first-page":"109","article-title":"MECOM: a Very Interesting Gene Involved also in Lymphoid Malignancies","volume":"45","author":"Liu","year":"2019","journal-title":"J Assoc Genet Technol"},{"key":"10.1016\/j.retram.2023.103426_bib0053","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0092-8674(02)01113-3","article-title":"ATR regulates fragile site stability","volume":"111","author":"Casper","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.retram.2023.103426_bib0054","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/emboj\/17.1.159","article-title":"Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints","volume":"17","author":"Cliby","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.retram.2023.103426_bib0055","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2017-03-776674","article-title":"Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes","volume":"130","author":"Tesson","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103426_bib0056","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/leu.2008.208","article-title":"Long-term follow-up of 111 patients with persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes","volume":"23","author":"Cornet","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2023.103426_bib0057","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1182\/bloodadvances.2021004668","article-title":"Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies","volume":"5","author":"Stengel","year":"2021","journal-title":"Blood Adv"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318623000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318623000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:40:31Z","timestamp":1762821631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318623000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2452318623000508"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2023.103426","relation":{},"ISSN":["2452-3186"],"issn-type":[{"type":"print","value":"2452-3186"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenetics in the management of clonal chromosomal abnormalities of undetermined significance and persistent polyclonal B-cell lymphocytosis: Guidelines from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2023.103426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103426"}}